Literature DB >> 334285

Interferons: anti-neoplastic drugs?

H Strander.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 334285     DOI: 10.1007/bf00996140

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


× No keyword cloud information.
  99 in total

1.  Interferon crosses blood-cerebrospinal fluid barrier in monkeys.

Authors:  D V Habif; R Lipton; K Cantell
Journal:  Proc Soc Exp Biol Med       Date:  1975-05

2.  Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies.

Authors:  K Berg; C A Ogburn; K Paucker; K E Mogensen; K Cantell
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

3.  Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.

Authors:  G W Jordan; R P Fried; T C Merigan
Journal:  J Infect Dis       Date:  1974-07       Impact factor: 5.226

4.  Production and purification of human leukocyte interferon.

Authors:  A Matsuo; S Hayashi; T Kishida
Journal:  Jpn J Microbiol       Date:  1974-01

5.  Letter: Inhibitory effect of potent interferon preparations on the regeneration of mouse liver after partial hepatectomy.

Authors:  C Frayssinet; I Gresser; M Tovey; P Lindahl
Journal:  Nature       Date:  1973-09-21       Impact factor: 49.962

6.  The somatic cell genetics of human interferon: assignment of human interferon loci to chromosomes 2 and 5.

Authors:  Y H Tan; R P Creagan; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

7.  Interferon and cell division. II. Influence of various experimental conditions on the inhibition of L1210 cell multiplication in vitro by interferon preparations.

Authors:  I Gresser; D Brouty-Boyé; M T Thomas; A Macieira-Coelho
Journal:  J Natl Cancer Inst       Date:  1970-12       Impact factor: 13.506

Review 8.  Human leukocyte interferon: production, purification, stability, and animal experiments.

Authors:  K Cantell; S Hirvonen; K E Mogensen; L Pyhälä
Journal:  In Vitro Monogr       Date:  1974

9.  Multiple active sites on human interferons.

Authors:  K Paucker; B J Dalton; C A Ogburn; E Törmä
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

10.  Administration of human fibroblast interferon in chronic hepatitis-B infection.

Authors:  J Desmyter; J De Groote; V J Desmet; A Billiau; M B Ray; A F Bradburne; V G Edy; P De Somer
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

View more
  18 in total

Review 1.  The potential of interferons in malignant disease.

Authors:  K Okita; T Kaneko
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

Review 2.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

Review 3.  Does interferon cure cancer?

Authors:  K Sikora
Journal:  Br Med J       Date:  1980-09-27

4.  Interferon production by a human lymphoblastoid cell line (DG-75) free of the Epstein-Barr genome.

Authors:  A Lazar; S Reuveny; M Minai; A Traub; A Mizrahi
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

5.  Effect of interferon in therapy of skin and head and neck tumors.

Authors:  I Padovan; I Brodarec; D Ikić; M Knezević; E Soos
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

6.  [Interferons--research, effects and importance].

Authors:  E Lodemann
Journal:  Naturwissenschaften       Date:  1984-11

Review 7.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

8.  Clinical and immunological studies of human fibroblast interferon.

Authors:  K Ezaki; M Ogawa; K Okabe; K Abe; K Inoue; N Horikoshi; J Inagaki
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Electrophoretically pure mouse interferon exerts multiple biologic effects.

Authors:  I Gresser; J De Maeyer-Guignard; M G Tovey; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

10.  Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.

Authors:  B Y Rubin; S L Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.